Randomized controlled trial examines vitamin C's impact on pharyngocutaneous fistulas in laryngeal cancer, suggesting further research is needed.
Background: Pharyngocutaneous fistula represents a significant complication following total laryngectomy. This study aims to explore the relationship between vitamin C administration and the formation of pharyngocutaneous fistulas. Materials and methods: This open-label randomized controlled trial involved 47 patients diagnosed with laryngeal cancer. Participants were randomly allocated to either an intervention group or a placebo group. Those in the intervention group received 1 gram of vitamin C via injection twice daily ( n = 23), while the placebo group received an equivalent volume of distilled water ( n = 24) during their postoperative recovery. The occurrence of pharyngocutaneous fistula was monitored in both groups after 1 month. Results: A total of 27.66% (13 patients) developed pharyngocutaneous fistulas. The incidence in the vitamin C group was lower at 21.74%, compared to 33.33% in the control group; however, this difference did not reach statistical significance ( P = 0.374). Conclusion: Although this study offers important insights into the potential impact of vitamin C on the postoperative care of laryngeal cancer patients, the results indicate that further research with larger sample sizes and varied methodologies is required to establish definitive conclusions.
No takes yet. Share an insight, caveat, or question.
Pasand et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: